Related Experiment Video

Updated: Jun 9, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Emerging targets for hematological malignancies

Daniela Cilloni1, Francesco Frassoni, Giuseppe Saglio

  • 1University of Turin, San Luigi Hospital, Department of Clinical and Biological Sciences, Gonzole 10, 10043 Orbassano-Torino, Italy. daniela.cilloni@unito.it

Current Opinion in Drug Discovery & Development
|September 3, 2010
PubMed

Insights

Targeted therapies are revolutionizing blood cancer treatment by focusing on specific molecular defects. Researchers are exploring ways to eliminate leukemic stem cells for more effective next-generation cancer drugs.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Molecularly targeted therapies are integral to treating hematological malignancies.
  • Identifying specific molecular defects in leukemic cells is key to advancing drug efficacy.
  • Leukemic stem cells represent a critical target for eradicating cancer.

Purpose of the Study:

  • To review novel oncogenetic mechanisms in hematological malignancies.
  • To identify druggable targets for next-generation therapies.
  • To explore strategies for eliminating leukemic stem cells.

Main Methods:

  • Literature review of recent research on oncogenetics in hematological malignancies.
  • Analysis of pathways involved in leukemic stem cell maintenance.
  • Evaluation of therapeutic approaches targeting leukemic stem cells.

Main Results:

  • Emerging insights into oncogenetic drivers of hematological cancers.
  • Identification of several potential molecular targets for drug development.
  • Discussion of strategies for selective leukemic stem cell eradication.

Conclusions:

  • Targeting oncogenetic mechanisms and leukemic stem cells offers a promising therapeutic avenue.
  • Further research into specific molecular defects can lead to more effective treatments for blood cancers.
  • Selective elimination of leukemic stem cells is a key goal for future hematological therapies.

More Related Videos

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...